BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22102368)

  • 1. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
    Cowan RW; Singh G; Ghert M
    J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells stimulate catabolic gene expression by the stromal cells from giant cell tumor of bone.
    Cowan RW; Ghert M; Singh G
    Biochem Biophys Res Commun; 2012 Mar; 419(4):719-23. PubMed ID: 22386994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression.
    Ng PK; Tsui SK; Lau CP; Wong CH; Wong WH; Huang L; Kumta SM
    J Cell Biochem; 2010 May; 110(2):438-46. PubMed ID: 20225273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
    Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone.
    Faucheux C; Horton MA; Price JS
    J Bone Miner Res; 2002 Mar; 17(3):455-64. PubMed ID: 11874237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of parathyroid hormone (PTH)-related peptide (PthrP) and PTH/PTHrP receptor in osteoclast-like giant cells.
    Nakashima M; Nakayama T; Ohtsuru A; Fukada E; Niino D; Yamazumi K; Naito S; Ito M; Sekine I
    Pathol Res Pract; 2003; 199(2):85-92. PubMed ID: 12747470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone-related peptide (PTHrP), parathyroid hormone/parathyroid hormone-related peptide receptor 1 (PTHR1), and MSX1 protein are expressed in central and peripheral giant cell granulomas of the jaws.
    Houpis CH; Tosios KI; Papavasileiou D; Christopoulos PG; Koutlas IG; Sklavounou A; Alexandridis C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):415-24. PubMed ID: 20060342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
    Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
    J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANK signalling in bone lesions with osteoclast-like giant cells.
    Won KY; Kalil RK; Kim YW; Park YK
    Pathology; 2011 Jun; 43(4):318-21. PubMed ID: 21532526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
    Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
    Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural and cytobiological studies on possible interactions between PTHrP-secreting tumor cells, stromal cells, and bone cells.
    Ito M; Amizuka N; Tanaka S; Funatsu-Ozawa Y; Kenmotsu S; Oda K; Nakajima T; Ozawa H
    J Bone Miner Metab; 2003; 21(6):353-62. PubMed ID: 14586791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells.
    Mak IW; Turcotte RE; Ghert M
    Bone; 2013 Jul; 55(1):198-207. PubMed ID: 23466453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
    Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
    Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
    Lau CP; Huang L; Wong KC; Kumta SM
    Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
    J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
    Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.